Literature DB >> 8731214

Synergistic induction of tumor necrosis factor alpha by bacterial lipopolysaccharide and lipoteichoic acid in combination with polytetrafluoroethylene particles in a murine macrophage cell line RAW 264.7.

M S Chapekar1, T G Zaremba, R K Kuester, V M Hitchins.   

Abstract

The induction of tumor necrosis factor alpha (TNF-alpha) by polytetrafluoroethylene (PTFE) particles (5-50 microns) and by bacterial lipopolysaccharide (LPS) and lipoteichoic acid (LTA) was examined in RAW cell cultures. Twenty-four-hour culture supernatants from the treated and control cells were assayed for TNF-alpha using a mouse L929 cell cytotoxicity assay. Untreated RAW cells produced low levels of endogenous TNF-alpha in the culture supernatants. Addition of 0.5 ng to 1 microgram/ mL LPS or 1 ng to 1 microgram/ml LTA increased the TNF-alpha production by 7-3570-fold and 2-815-fold, respectively. Addition of 1-5 mg PTFE increased the TNF-alpha production by 6-17-fold over the untreated control cell levels. The cells exposed to PTFE and 0.5 ng/mL LPS or 5 ng/mL LTA produced TNF-alpha levels that were significantly higher than those produced by any inducer alone. Thus, both LTA, a Gram-positive bacterial cell wall component and LPS, a Gram-negative bacterial cell wall component, can induce TNF-alpha production, which is further enhanced by PTFE particles in RAW cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8731214     DOI: 10.1002/(SICI)1097-4636(199606)31:2<251::AID-JBM12>3.0.CO;2-O

Source DB:  PubMed          Journal:  J Biomed Mater Res        ISSN: 0021-9304


  7 in total

1.  Cellular response to phase-separated blends of tyrosine-derived polycarbonates.

Authors:  LeeAnn O Bailey; Matthew L Becker; Jean S Stephens; Nathan D Gallant; Christine M Mahoney; Newell R Washburn; Aarti Rege; Joachim Kohn; Eric J Amis
Journal:  J Biomed Mater Res A       Date:  2006-03-01       Impact factor: 4.396

2.  Comparison of polymeric siRNA nanocarriers in a murine LPS-activated macrophage cell line: gene silencing, toxicity and off-target gene expression.

Authors:  Linda B Jensen; Joscha Griger; Broes Naeye; Amir K Varkouhi; Koen Raemdonck; Raymond Schiffelers; Twan Lammers; Gert Storm; Stefaan C de Smedt; Brian S Sproat; Hanne M Nielsen; Camilla Foged
Journal:  Pharm Res       Date:  2011-10-05       Impact factor: 4.200

3.  Blueprints of signaling interactions between pattern recognition receptors: implications for the design of vaccine adjuvants.

Authors:  Kim Timmermans; Theo S Plantinga; Matthijs Kox; Michiel Vaneker; Gert Jan Scheffer; Gosse J Adema; Leo A B Joosten; Mihai G Netea
Journal:  Clin Vaccine Immunol       Date:  2013-01-23

4.  Model-driven multi-omic data analysis elucidates metabolic immunomodulators of macrophage activation.

Authors:  Aarash Bordbar; Monica L Mo; Ernesto S Nakayasu; Alexandra C Schrimpe-Rutledge; Young-Mo Kim; Thomas O Metz; Marcus B Jones; Bryan C Frank; Richard D Smith; Scott N Peterson; Daniel R Hyduke; Joshua N Adkins; Bernhard O Palsson
Journal:  Mol Syst Biol       Date:  2012-06-26       Impact factor: 11.429

5.  Iron oxide nanoparticles modulate lipopolysaccharide-induced inflammatory responses in primary human monocytes.

Authors:  Susann Grosse; Jørgen Stenvik; Asbjørn M Nilsen
Journal:  Int J Nanomedicine       Date:  2016-09-13

6.  Graphene Oxide Nanosheets for Localized Hyperthermia-Physicochemical Characterization, Biocompatibility, and Induction of Tumor Cell Death.

Authors:  Malgorzata J Podolska; Alexandre Barras; Christoph Alexiou; Benjamin Frey; Udo Gaipl; Rabah Boukherroub; Sabine Szunerits; Christina Janko; Luis E Muñoz
Journal:  Cells       Date:  2020-03-23       Impact factor: 6.600

7.  PEGylated Nanographene Oxide in Combination with Near-Infrared Laser Irradiation as a Smart Nanocarrier in Colon Cancer Targeted Therapy.

Authors:  Milena Georgieva; Zlatina Gospodinova; Milena Keremidarska-Markova; Trayana Kamenska; Galina Gencheva; Natalia Krasteva
Journal:  Pharmaceutics       Date:  2021-03-22       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.